Pacific Biosciences of California Inc (PACB)
Drugs • Health Care
Percentage
Change
| Mar 12 | Mar 13 | Mar 14 | Mar 15 | Mar 16 | Mar 17 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 22 | Feb 23 | Feb 24 | Mar 25 | Feb 26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income to Common | -310 | -546 | |||||||||||||
Net Income | -310 | -546 | |||||||||||||
Profit | -310 | -546 | |||||||||||||
Net Income Continuing | -310 | -546 | |||||||||||||
Income Tax Expense | -0 | -0 | |||||||||||||
Pretax Income | -310 | -546 | |||||||||||||
Total Non-operating Income | 165 | 8 | |||||||||||||
Operating Income | -474 | -554 | |||||||||||||
Total Revenue | 154 | 160 | |||||||||||||
Total Costs and Expenses | -628 | -714 | |||||||||||||
Cost of Revenue | -117 | -114 | |||||||||||||
Operating Expenses | -512 | -600 | |||||||||||||
Depreciation, Depletion & Amortization Expense | 0 | -365 | |||||||||||||
Impairment Expense | -185 | -15 | |||||||||||||
Research and Development Expenses | -135 | -97 | |||||||||||||
Selling, General & Administrative Expenses | -175 | -141 | |||||||||||||
Other Operating Expenses | -17 | 19 |